Hepatitis B and C infection in haemodialysis patients in Libya: prevalence, incidence and risk factors

被引:50
|
作者
Alashek, Wiam A. [1 ]
McIntyre, Christopher W. [1 ,2 ]
Taal, Maarten W. [2 ]
机构
[1] Univ Nottingham, Sch Grad Entry Med, Nottingham NG7 2RD, England
[2] Derby Hosp NHS Fdn Trust, Dept Renal Med, Derby, England
来源
BMC INFECTIOUS DISEASES | 2012年 / 12卷
关键词
Haemodialysis; Hepatitis B; Hepatitis C; Incidence; Libya; Nosocomial infection; Prevalence; VIRUS-INFECTION; BLOOD-TRANSFUSIONS; MOLECULAR EVIDENCE; DIALYSIS PATIENTS; LIVER-DISEASE; CONTINENTS; UNITS; POPULATION; SEROCONVERSION; EPIDEMIOLOGY;
D O I
10.1186/1471-2334-12-265
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background: Patients receiving maintenance haemodialysis (HD) are at higher risk for acquiring Hepatitis B Virus (HBV) and Hepatitis C Virus (HCV) infections than the general population. Strict infection control measures are essential to prevent nosocomial transmission. We aimed to investigate the incidence and prevalence of HBV and HCV infection in the HD population of Libya as well as risk factors for infection. Methods: All adult patients receiving maintenance HD (n=2382) in Libyan dialysis centres (n=39) were studied between May 2009 and October 2010. Testing for Hepatitis B surface antigen (HBsAg) and anti-HCV antibodies was performed at initiation of dialysis and every 3-6 months thereafter. Patients who were sero-negative for HBV and HCV (n=1160) were followed up for 1 year to detect sero-conversions. Results: Participant median age was 49 years and 58% were male. 831 patients (34.9%) were sero-positive for HBV and/or HCV (anti-HCV positive 31.1%; HBsAg positive 2.6%; both positive 1.2%). Of the sero-positive patients 4.7% were known to be infected before the initiation of HD. The prevalence of HBV +/- HCV infection varied widely between HD centres from 0% to 75.9%. Sero-positive patients were younger, had longer time on dialysis and more previous blood transfusions. Prospective follow-up revealed an incidence of sero-conversion of 7.7% during 1 year (7.1% HCV; 0.6% HBV). Wide variation in rates of newly acquired infections was observed between dialysis centres. All new HBV cases were referred from centres already treating HBV infected patients. New HCV infections were reported in most centres but the rate of HCV sero-conversion varied widely from 1.5% to 31%. Duration of dialysis, history of previous renal transplant and history of receiving HD in another centre in Libya were significantly associated with sero-conversion. Conclusion: Patients on maintenance HD in Libya have a high incidence and prevalence of HCV infection and lower rates of HBV infection. The factors associated with HBV and HCV infection are highly suggestive of nosocomial transmission within HD units. Urgent action is required to improve infection control measures in HD centres and to reduce dependence on blood transfusions for the treatment of anaemia.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] PREVALENCE OF HEPATITIS B CORE ANTIBODY AND OCCULT INFECTION AMONG HAEMODIALYSIS PATIENTS
    Mooppil, Nandakumar
    Aithal, Seema
    Ibakkanavar, Rajiva
    Singh, Tripti
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 : 1770 - 1770
  • [22] Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey
    Daw, Mohamed A.
    El-Bouzedi, Abdallah
    BMC INFECTIOUS DISEASES, 2014, 14
  • [23] Prevalence of hepatitis B and hepatitis C infection in Libya: results from a national population based survey
    Mohamed A Daw
    Abdallah El-Bouzedi
    BMC Infectious Diseases, 14
  • [24] Prevalence of and risk factors for hepatitis B and C infection among Mongolian blood donors
    Tserenpuntsag, Boldtsetseg
    Nelson, Kenrad
    Lamjav, Ouynbileg
    Triner, Wayne
    Smith, Perry
    Kacica, Marilyn
    McNutt, Louise-Anne
    TRANSFUSION, 2010, 50 (01) : 92 - 99
  • [25] Prevalence of hepatitis B markers in patients with hepatitis C infection in north-eastern Poland: Risk factors and vaccine use
    Sławomir Chlabicz
    Anna Grzeszczuk
    European Journal of Epidemiology, 2001, 17 : 267 - 270
  • [26] Prevalence of hepatitis B markers in patients with hepatitis C infection in north-eastern Poland: Risk factors and vaccine use
    Chlabicz, S
    Grzeszczuk, A
    EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2001, 17 (03) : 267 - 270
  • [27] Prevalence and risk factors of hepatitis B and C among hemodialysis patients in Tunisia
    Mhalla, S.
    Hammoud, R.
    Frih, A.
    Kadri, Y.
    El Argoubi, A.
    Elmay, M.
    Mastouri, M.
    MEDECINE ET MALADIES INFECTIEUSES, 2018, 48 (03): : 175 - 179
  • [28] The prevalence and the risk factors for hepatitis C virus infection in Serbia
    Mitrovic, Nikola
    Delic, Dragan
    Denic, Ljiljana Markovic
    Nikolic, Natasa
    Bojovic, Ksenija
    Babic, Jasmina Simonovic
    Brmbolic, Branko
    Milosevic, Ivana
    Katanic, Natasa
    Barac, Aleksandra
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2018, 12 (03): : 171 - 177
  • [29] Prevalence of hepatitis C virus infection in adults with the risk factors
    Dyrhonova, M.
    Haskova, K.
    Vranova, J.
    Chlibek, R.
    EPIDEMIOLOGIE MIKROBIOLOGIE IMUNOLOGIE, 2019, 68 (01): : 9 - 14
  • [30] Hepatitis C infection among primary health care patients: prevalence and risk factors
    Ciupkeviciene, Egle
    Dragunas, G.
    Dabravalskis, S.
    Petkeviciene, J.
    Kupcinskas, L.
    EUROPEAN JOURNAL OF PUBLIC HEALTH, 2021, 31